BeStock  
Stocks › Biotechnology › NKTR

Nektar Therapeutics NKTR

US equityMarket cap rank #3135Biotechnology
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

NKTR Stock News

Headlines matching Nektar Therapeutics or the NKTR ticker, most recent first.

  • BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $178Market news · 30 Sep 2026 · Direct mention
  • CCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153Market news · 28 Sep 2026 · Direct mention
  • Nektar Therapeutics | SCHEDULE 13G/A: OthersSEC · 28 Sep 2026 · Related
  • Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GREER R SCOTTSEC · 26 Sep 2026 · Related
  • Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WHITFIELD ROY ASEC · 26 Sep 2026 · Related
  • Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $192Market news · 20 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $80 to $192Market news · 15 Aug 2026 · Direct mention
  • CCORF Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $153Market news · 22 Jul 2026 · Direct mention
  • Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $192 PositiveMarket news · 8 May 2026 · Direct mention
  • TD Cowen Maintains Nektar Therapeutics(NKTR.US) With Buy RatingMarket news · 8 May 2026 · Direct mention
  • Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $140 PositiveMarket news · 8 May 2026 · Direct mention
  • Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $123Market news · 7 Apr 2026 · Direct mention
  • H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Cuts Target Price to $135 NegativeMarket news · 6 Apr 2026 · Direct mention
  • Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $151 PositiveMarket news · 21 Apr 2026 · Direct mention
  • A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $134 to $185Market news · 21 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on NKTR.

Sign in to join the discussion.

Scroll to Top